Michael G. Carter, Director at Oncternal Therapeutics, holds 71.95K shares in Oncternal Therapeutics (Ticker: ONCT), holds 0.00 shares in Santarus (Ticker: SNTS). Most recently, Michael G. Carter Bought ― shares of Oncternal Therapeutics on Sep 02, 2020 for an estimated value of 150.00K.